Coordinated Signaling Pathways in Airway Epithelium Connect Allergen-Induced Inflammation to Structural Changes in Asthma
By
Shin-Young Park
July 20, 2026
Clinical Scorecard: Coordinated Signaling Pathways in Airway Epithelium Connect Allergen-Induced Inflammation to Structural Changes in Asthma
At a Glance
Category Detail
Condition Asthma Key Mechanisms Integrated signaling pathways in airway epithelium including EGFR, MAPK, PI3K/AKT, NF-κB, JAK/STAT, and TGF-β/SMAD. Target Population Individuals with asthma, particularly those with T2-high and T2-low endotypes. Care Setting Clinical management of chronic inflammatory airway diseases.
Key Highlights
Asthma is characterized by chronic inflammation and structural remodeling of the airways. Airway epithelium plays a crucial role in sensing allergens and orchestrating immune responses. Epithelial dysregulation contributes to asthma pathogenesis and treatment resistance. Asthma endotypes include T2-high eosinophilic and T2-low neutrophilic or mixed types. Current biologics target specific pathways but may not benefit all patients. Guideline-Based Recommendations
Diagnosis
Asthma diagnosis should consider clinical history, symptom patterns, and lung function tests. Management
Inhaled corticosteroids are the mainstay of asthma management, with biologics for specific endotypes. Monitoring & Follow-up
Regular assessment of asthma control and lung function is essential for management. Risks
Patients with T2-low asthma may have unmet therapeutic needs and limited response to current treatments. Patient & Prescribing Data
Patients with asthma, particularly those with varying endotypes.
Biologics targeting IL-5, IL-4Rα, IgE, and TSLP are effective for T2-high asthma.
Clinical Best Practices
Utilize a network-level analysis of epithelial activation for understanding asthma mechanisms. Consider endotype-specific therapies for personalized asthma management. Monitor for treatment resistance and adjust management strategies accordingly. Related Resources & Content
